Morning Read: Mylan acquires Sweden’s Meda for $9.9B, pharmacists fight opioid addiction
Also, medical journals, NGOs and research funders to share Zika data, while Humana considers exiting the Obamacare marketplace.
Morning Read: EMR vendor grades are in (it doesn’t look good)
Also, the Mylan-Perrigo hostile takeover is underway, Medtronic gets an FDA approval and new population health innovations are popping up throughout the country.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Teva snags Auspex Pharmaceutical for $3.5B, PTC acquires ColdLight (Morning Read)
TOP STORIES Teva has completed its $3.5-billion purchase of Auspex Pharmaceuticals – still keeping an eye on Mylan, though. PTC announced it has signed a definitive agreement to acquire ColdLight, a visionary in big data machine learning and predictive analytics, for approximately $105 million. LIFE SCIENCE A plant-derived compound could target cancer stem cells. […]
NIH increase moves out of committee, Teva keeps courting Mylan (Morning Read)
TOP STORIES Leaders of the House Energy and Commerce Committee have reached a deal on a draft of legislation that will speed up the approval of new drugs and treatments. Funding for the NIH — which had been a deeply disputed issue within the committee — will rise by $10 billiion over five years if […]
Mylan rejects Teva’s $40B bid, Medtronic stops distribution of pain med pump (Morning Read)
Mylan has rejected Teva's unsolicited bid. Intarcia Therapeutics raised $225 million to develop its implantable drug-delivery pump for patients with diabetes. Plus, Medtronic has agreed to halt production and distribution of its SynchroMed implantable drug pump.
Teva makes its move on Mylan, medical startups raise a record $3.9B in Q1 (Morning Read)
Teva started its bid for Mylan on Tuesday. They are confident - even though Myland said "no thanks" back on Friday. Read about this, the latest stats on investing in medical startups and more in The Morning Read.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Mylan’s bid to buy Perrigo could mark the biggest pharma deal of the year, Obama gives Obamacare an 8 out of 10 rating (Morning Read)
TOP STORIES Despite criticism and disapproval by some, the president gives Obamacare an 8 out of 10 rating – not giving it a ten because you can “always improve something.” “Sixteen million people or more have health insurance that didn’t have it before,” Obama said. He added that has led to the lowest uninsured rate […]